On April 13, 2023, the Federal Trade Commission (FTC) put almost ~670 companies involved in the marketing of OTC drugs, homeopathic products, dietary supplements, or functional foods on notice regarding the agency’s claim substantiation expectations for health-benefit and safety claims. The FTC’s notice letter is intended to alert companies engaged in the marketing or sale of health-related products that they could incur steep civil penalties (up to $50,120 per violation) if they fail adequately to substantiate their health and safety claims for such products.

...